Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis

Global Amyotrophic Lateral Sclerosis Market to Reach $3.2 Billion by 2030
In the changed post COVID-19 business landscape, the global market for Amyotrophic Lateral Sclerosis estimated at US$772.8 Million in the year 2022, is projected to reach a revised size of US$3.2 Billion by 2030, growing at a CAGR of 19.3% over the period 2022-2030.

The U.S. Market is Estimated at $235.4 Million, While China is Forecast to Grow at 18.4% CAGR
The Amyotrophic Lateral Sclerosis market in the U.S. is estimated at US$235.4 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$534.5 Million by the year 2030 trailing a CAGR of 18.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 17.2% and 16.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 14.2% CAGR.

Select Competitors (Total 23 Featured) -

• AB Science SA
• Apotex, Inc.
• Aquestive
• Biogen, Inc.
• Brainstorm Cell Therapeutics Inc.
• Cytokinetics, Inc.
• F. Hoffmann-La Roche AG
• Genervon Biopharmaceuticals LLC
• Ionis Pharmaceuticals, Inc.
• Kringle Pharma Inc.
• Mitsubishi Tanabe Pharma Corporation
• Neuralstem, Inc.
• Orion Corporation
• Orphazyme A/S
• Sanofi SA
• Treeway BV
• Valeant Pharmaceuticals International, Inc.
• ViroMed Co., Ltd.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.